🇺🇸 FDA
Patent

US 10233463

Neurotensin-induced tumor formation is regulated by micro RNA 133A-aftiphilin-dependent receptor recycling

granted A61KA61K38/00A61K38/1709

Quick answer

US patent 10233463 (Neurotensin-induced tumor formation is regulated by micro RNA 133A-aftiphilin-dependent receptor recycling) held by The Regents of the University of California expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00, A61K38/1709, A61P, A61P35/00